FORSTEO(R) Receives Approval From The European Commission For The Treatment Of Glucocorticoid Induced Osteoporosis Eli Lilly and Company (NYSE: LLY) announced that the European Commission has approved a new indication for FORSTEO(R) (teriparatide [rDNA origin] injection) for the treatment of osteoporosis associated with sustained, systemic glucocorticoid therapy in women and men at increased risk for fracture.
Source: www.medicalnewstoday.comDoes Open Heart Surgery Cause Cognitive Decline? Rigorous Study Says "No" For many years, assumptions have lingered that Coronary Artery Bypass Surgery Grafting (CABG) produces measurable cognitive impairment, either because of the surgery or use of cardiopulmonary bypass. Recent studies have failed to resolve the issue, because of complications in cognitive testing processes and comparison methods.
Source: www.medicalnewstoday.comHealth Benefits Discovered In Natural Trans Fats, University Of Alberta Study Shows Contrary to popular opinion, not all trans fats are bad for you.
Source: www.medicalnewstoday.comSequencing Of Giant Panda Genome Cardiff University is contributing to the first genome project to assist conservation efforts for an endangered species.Researchers in the Cardiff School of Biosciences will work with international colleagues on the 'Giant Panda Genome Project'.The panda is often referred to as a 'living fossil', given evidence that its ancestors existed in China more than 8 million years ago.
Source: www.medicalnewstoday.comPieces Coming Together In Parkinson's, Cholesterol Puzzle In 2006, University of North Carolina at Chapel Hill researchers published a study that found people with low levels of LDL cholesterol are more likely to have Parkinson's disease than people with high LDL levels.
Source: www.medicalnewstoday.comLatest Trends And News In Health Care At 5th Annual World Health Care Congress April 21-23, Washington, D.C. The World
Health Care Congress is the premier forum for
health care executives to explore a myriad of emerging issues and to network with key leaders. The 2008 Congress will include senior executives and government officials from the nation's largest employers, hospitals,
health systems,
health plans, pharmaceutical and biotech companies, and government.
Source: www.medicalnewstoday.comFirst New NNRTI In Nearly A Decade To Benefit Canadians With HIV/AIDS Canadians living with HIV/AIDS now have a new
prescription treatment option, with the recent approval of INTELENCE (etravirine, also known as TMC125) from Tibotec, a division of Janssen-Ortho Inc. INTELENCE is the newest member of the family of AIDS-fighting
drugs known as non-nucleoside reverse transcriptase inhibitors (NNRTI), and is the first new NNRTI to be introduced in nearly 10 years.
Source: www.medicalnewstoday.comICAD Receives FDA Approval For Its SecondLook Digital For Use With Fuji's Digital Mammography System iCAD(R), Inc. (Nasdaq: ICAD), an industry-leading provider of Computer-Aided Detection (CAD) solutions, announced that iCAD's SecondLook(R) Digital Computer-Aided Detection system for mammography received approval from the U.S. Food and Drug Administration for sale with Fujifilm Computed Radiography for Mammography (FCRm) systems.
Source: www.medicalnewstoday.comPediatric Gymnastics Related Injuries A Concern More than 600,000 children participate in school-sponsored and club-level gymnastics competitions annually in the United States. Yet gymnastics continues to be overlooked in terms of potential for injury, while having one of the highest injury rates of all girls' sports.
Source: www.medicalnewstoday.comVaccine Induced Inflammation Linked To Epidemic Of Type 2 Diabetes And Metabolic Syndrome Newly published data by Dr. J. Barthelow Classen in The Open Endocrinology Journal shows a 50% reduction of type 2 diabetes occurred in Japanese children following the discontinuation of a single vaccine, a vaccine to prevent tuberculosis.
Source: www.medicalnewstoday.com
# posted by Network @ 7:00 AM
